Monolithic Power Systems Inc vs State Street SPDR S&P Biotech ETF — how do they compare? Monolithic Power Systems Inc trades at $1,428 (market cap $68.90B), while State Street SPDR S&P Biotech ETF trades at $158.28. The key difference: Monolithic Power Systems Inc pays a 0.57% dividend while State Street SPDR S&P Biotech ETF pays none. Which is the better fit depends on your goals.
| MPWR | XBI | |
|---|---|---|
Market Cap | $68.90B | — |
Sector | Utilities | Broad Market / Factor |
52-Week High | $1.69K | $164.28 |
52-Week Low | $820.74 | $86.92 |
Enterprise Value | $67.51B | — |
Dividend Yield | 0.57% | — |
Trailing returns across standard periods
Latest headlines on both assets
Monolithic Power Systems, Inc. is a global leader in high-performance, analog, and mixed-signal semiconductors. The company specializes in power management solutions, providing integrated circuits (ICs) for a wide range of applications, including computing, automotive, industrial, and communications. MPWR's proprietary process technology is designed to deliver highly energy-efficient and compact power solutions, positioning the company as a key supplier for the next generation of electronic devices.
Read more on MPWR →XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →